Foradil Certihaler Articles
Almirall starts Ph III COPD trial; collaborates with BioFocus; and posts sales and earnings downturn
16 November 2011
SkyePharma/Novartis' Foradil Certihaler launched in Germany
12 September 2005
SkyePharma sees net loss fall for 1st-half 2004, as sales rise and R&D costs decrease
20 September 2004
First Euro appro for Skye/Novartis' Foradil
15 March 2004
Novartis inhaler filing boosts SkyePharma
6 January 2003
Novartis' Foradil cleared for COPD in USA; new data on Xolair
27 September 2001
Foradil gets OK for maintenance in USA
19 February 2001
Showing 1-8 of 8 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
